⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLRS News
Clear Street Group Inc. Class A Common Stock
Peripheral Artery Disease Clinical Trial Pipeline Expands as 17+ Companies Race to Redefine Peripheral Artery Disease Treatment Landscape | DelveInsight
globenewswire.com
CLRS
MDT
PHG
BSX
BDX
BIOT
ABT
ANGI
RMAX
MRK
SNY
JNJ
BA
GSK
AZN
PFE
NVO
AMGN
VRTX
Claros Technologies Appoints Jack Cogen to Board of Directors
prnewswire.com
CLRS
CWCO
Claros Technologies Appoints Jack Cogen to Board of Directors
prnewswire.com
CLRS
Clearsense Launches Managed Service for Continuous Application Rationalization and Active Archiving
globenewswire.com
CLRS
Cellares and ProTgen Partner to Automate Manufacturing for ProT-096, a Novel Progenitor T Cell Therapy Designed to Restore Immune Competence
businesswire.com
CLRS
Clarios wins BCI's 2026 Amplify Award for Product Marketing
accessnewswire.com
CLRS
FDA Grants Fast Track Designation for CS-1103, a First-in-class Small Molecule to Reverse Acute Intoxication from Fentanyl
prnewswire.com
CLRS
CLAIRE'S USHERS IN A NEW ERA OF MODERN GIRLHOOD
prnewswire.com
CLRS
U.S. Army PaYS Program, Clarios Partner to Create Career Pathways for Local Transitioning Soldiers
globenewswire.com
CLRS
Salus Scientific Appoints Medical Device Executive Will Martin to Board of Directors
prnewswire.com
CLRS
PHG